Minimizing the potential adverse effects of clinical investigators' financial conflicts of interest involves, in part, determining how much of an investigator's 'business' should be disclosed to participants in research studies. What should be disclosed and why? How will we know if disclosure matters?
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Weinfurt, K. P. et al. Disclosure of financial relationships to participants in clinical research. N. Engl. J. Med. 361, 916–921 (2009).
Association of American Medical Colleges and Association of American Universities. Protecting patients, preserving integrity, advancing health: accelerating the implementation of COI policies in human subjects research. A Report of the AAMC-AAU Advisory Committee on Financial Conflicts of Interest in Human Subjects Research. (Association of American Medical Colleges, Washington, DC, 2008).
Lo, B. & Field, M. J. (eds) Conflict of interest in medical research, education, and practice (The National Academies Press, Washington, DC, 2009).
Thompson, D. F. Understanding financial conflicts of interest. N. Engl. J. Med. 329, 573–576 (1993).
Levinsky, N. G. Nonfinancial conflicts of interest in research. N. Engl. J. Med. 347, 759–761 (2002).
Sollitto, S. et al. Intrinsic conflicts of interest in clinical research: a need for disclosure. Kennedy Inst. Ethics J. 13, 83–91 (2003).
Gray, S. W., Hlubocky, F. J., Ratain, M. J. & Daugherty, C. K. Attitudes toward research participation and investigator conflicts of interest among advanced cancer patients participating in early phase clinical trials. J. Clin. Oncol. 25, 3488–3494 (2007).
Elliott, K. C. Scientific judgment and the limits of conflict-of-interest policies. Account. Res. 15, 1–29 (2008).
Kim, S. Y. H., Millard, R. W., Nisbet, P., Cox, C. & Caine, E. D. Potential research participants' views regarding researcher and institutional financial conflicts of interest. J. Med. Ethics 30, 73–79 (2004).
Romain, P. L. Access to clinical care via clinical trials: is it ethically possible? Nat. Clin. Pract. Rheum. 4, 166–167 (2008).
Author information
Authors and Affiliations
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Romain, P. Investigators' interests: what should trial participants be told?. Nat Rev Rheumatol 6, 70–71 (2010). https://doi.org/10.1038/nrrheum.2009.264
Issue Date:
DOI: https://doi.org/10.1038/nrrheum.2009.264
This article is cited by
-
The ethical challenges in rheumatology
Current Reviews in Musculoskeletal Medicine (2015)
-
Conflicts of interest in research: looking out for number one means keeping the primary interest front and center
Current Reviews in Musculoskeletal Medicine (2015)
